Stock Market

Entera Bio GAAP EPS of -$0.25 beats by $0.03, revenue of $0.04M in-line

By Bullbit Editorial · March 27, 2026

WhatEntera Bio reported a GAAP EPS of -$0.25, beating estimates by $0.03.
WhyThe company's revenue of $**0.04M** came in line with expectations.
SignalThis result may indicate a stabilization in the company's financial performance.
TargetInvestors may be looking for Entera Bio to achieve profitability in the near future.
RiskThe company's negative EPS suggests ongoing operational challenges.